ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near Austin, TX, USA:

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec (OPTI-2)

blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring t...

Enrolling
Diabetes Mellitus, Type 1
Drug: Lispro
Drug: HDV-Lispro

Phase 2

Diasome Pharmaceuticals

Austin, Texas, United States of America and 26 other locations

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Austin, Texas, United States and 24 other locations

of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...

Enrolling
Diabetes Mellitus, Type 2
Hypercortisolism
Drug: Mifepristone 300 MG [Korlym]
Drug: Placebo for mifepristone

Phase 4

Corcept Therapeutics
Corcept Therapeutics

Cedar Park, Texas, United States and 35 other locations

double-blind, placebo-controlled study of HTD1801 in adult subjects with non-alcoholic steatohepatitis and liver fibrosis who have type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Nonalcoholic Steatohepatitis (NASH)
Drug: Placebo
Drug: HTD1801

Phase 2

HighTide Therapeutics

Austin, Texas, United States and 54 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Austin, Texas, United States of America and 37 other locations

Evaluate the Safety, Tolerability, and Efficacy of OTX-TKI in Subjects with Moderately Severe to Severe Non-proliferative Diabetic Retinopat...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Drug: OTX-TKI
Drug: Sham

Phase 1

Ocular Therapeutix
Ocular Therapeutix

Austin, Texas, United States and 9 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Austin, Texas, United States and 175 other locations

Phase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus....

Active, not recruiting
Type 1 Diabetes Mellitus
Drug: BMF-219

Phase 2

Biomea Fusion

Round Rock, Texas, United States of America and 30 other locations

The purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes. This study will test the ....

Begins enrollment in 4 months
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Device: Continuous Glucose Monitoring
Medtronic
Medtronic

Austin, Texas, United States and 24 other locations

The objective of the study is to assess the safety and effectiveness of MiniMed™ 780G system in adult subjects with insulin-requiring type 2 diabetes...

Active, not recruiting
Type 2 Diabetes Treated with Insulin
Device: MiniMed™ 780G Insulin Pump system
Medtronic
Medtronic

Austin, Texas, United States and 30 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems